 | | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 "Although there is room for improvement, particularly in very high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago," study author Dr. David D. Waters, a professor emeritus of medicine at the University of California, San Francisco, said in the news release.
The rates of achieving the LDL goals ranged from 47 percent in Spain to 84 percent in South Korea, a variation the researchers were at a loss to explain. The other countries in the study, besides the United States, were Brazil, Canada, France, Mexico, the Netherlands and Taiwan.
The study was funded by Pfizer, Inc., maker of the statin drug, Lipitor.
Text Continues Below
More information
The National Cholesterol Education Program has more about high blood cholesterol.
Page: << Prev | 1 | 2
-- Kevin McKeever
|
.gif)
